Skip to content

Effect of intravenous analgesia pump with esketamine on postoperative analgesia and postpartum depression in parturients undergoing cesarean section: a double blind, randomized, controlled study

Effect of intravenous analgesia pump with esketamine on postoperative analgesia and postpartum depression in parturients undergoing cesarean section: a double blind, randomized, controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044178
Enrollment
Unknown
Registered
2021-03-12
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression

Interventions

Esketamine Group:Esketamine

Sponsors

Mengcheng County No.1 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 --45 years; (2) ASA II; (3) More than 28 weeks of gestation; (4) Postoperative analgesia was required; (5) No serious cardiovascular and cerebrovascular diseases were found; (6) The puerpera can communicate well with the follow-up; (7) Volunteer to participate in this study and sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: (1) There were pregnancy induced hypertension, thyroid dysfunction, preeclampsia and eclampsia, psychosis, inability to communicate pain response; (2) Abnormal increase of uterine activity, such as ankylosing uterine contraction, placental abruption and umbilical cord prolapse; (3) Contraindications of epidural catheterization such as history of spinal trauma or deformity; (4) Opioid allergy or history of opioid abuse; (5) Patients with severe risk of elevated blood pressure or intracranial pressure; (6) Patients with poorly controlled or untreated hypertension; (7) The fetus was seriously abnormal; (8) Pernicious placenta previa; (9) The patients who have received labor analgesia; (10) Other conditions considered by the researchers to be unsuitable for further treatment.

Design outcomes

Primary

MeasureTime frame
Incidence of postpartum depression at 1 month;Pain score of Parturient and times of analgesia pump pressing within 48 hours after delivery;Sleep quality of Parturient at 1d, 7d and 1 monthafter delivery;

Secondary

MeasureTime frame
BP, HR, SpO2, ECG and RR at the time points of intraoperative anesthesia (T0), 2 min after anesthesia (T1), fetal delivery (T2), 5 min after fetal delivery (T4) and leaving the operating room (T4).;Perioperative consumption of analgesics;

Countries

China

Contacts

Public ContactXiaoqiang Zhang

Mengcheng County No.1 People's Hospital

zxqahl@126.com+86 13309670321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026